**Biomy Teams Up with 10x Genomics to Revolutionize Cell Analysis with AI-Powered Virtual Cells**
Japanese biotech company biomy has announced a partnership with 10x Genomics, a US-based company listed on the NASDAQ stock exchange, to advance the field of cell analysis using artificial intelligence (AI). The collaboration will focus on leveraging the Xenium platform, a cutting-edge tool for in situ analysis, to create a more accurate and efficient Virtual Cell.
The partnership brings together two industry leaders in their respective fields. biomy, a Tokyo-based company, has been at the forefront of developing AI-driven solutions for biological research, while 10x Genomics has established itself as a pioneer in single-cell analysis technologies. 10x Genomics Vice President, Dr. Sudhir K. Singh, highlighted the significance of this collaboration, stating that it will “accelerate the development of AI-driven cell analysis and unlock new insights into cellular biology.”
The Xenium platform, a key component of the partnership, will be used to analyze and model the behavior of individual cells in a virtual environment. By combining the power of AI with the capabilities of Xenium, researchers will be able to create more accurate and detailed models of cellular behavior, leading to breakthroughs in fields such as cancer research, regenerative medicine, and synthetic biology.
**What this means**: This partnership has the potential to revolutionize the way we understand and analyze cellular behavior, leading to new treatments and therapies for a range of diseases. By advancing the field of AI-driven cell analysis, biomy and 10x Genomics are paving the way for a future where researchers can make more accurate predictions and develop more effective solutions for complex biological problems.
The collaboration between biomy and 10x Genomics marks an exciting new chapter in the development of AI-powered tools for biological research. With the Xenium platform at its core, this partnership has the potential to drive significant advancements in our understanding of cellular biology and lead to new discoveries in the years to come.
